Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7)
Publication
, Journal Article
Posner, MC; Niedzwiecki, D; Venook, AP; Hollis, DR; Kindler, HL; Martin, EW; Schilsky, RL; Goldberg, RM; Mayer, RJ
Published in: Annals of Surgical Oncology
August 1, 2009
Duke Scholars
Published In
Annals of Surgical Oncology
DOI
EISSN
1534-4681
ISSN
1068-9265
Publication Date
August 1, 2009
Volume
16
Issue
8
Start / End Page
2381
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Posner, M. C., Niedzwiecki, D., Venook, A. P., Hollis, D. R., Kindler, H. L., Martin, E. W., … Mayer, R. J. (2009). Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7). Annals of Surgical Oncology, 16(8), 2381. https://doi.org/10.1245/s10434-009-0466-9
Posner, M. C., D. Niedzwiecki, A. P. Venook, D. R. Hollis, H. L. Kindler, E. W. Martin, R. L. Schilsky, R. M. Goldberg, and R. J. Mayer. “Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7).” Annals of Surgical Oncology 16, no. 8 (August 1, 2009): 2381. https://doi.org/10.1245/s10434-009-0466-9.
Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, et al. Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7). Annals of Surgical Oncology. 2009 Aug 1;16(8):2381.
Posner, M. C., et al. “Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7).” Annals of Surgical Oncology, vol. 16, no. 8, Aug. 2009, p. 2381. Scopus, doi:10.1245/s10434-009-0466-9.
Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ. Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7). Annals of Surgical Oncology. 2009 Aug 1;16(8):2381.
Published In
Annals of Surgical Oncology
DOI
EISSN
1534-4681
ISSN
1068-9265
Publication Date
August 1, 2009
Volume
16
Issue
8
Start / End Page
2381
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis